C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 38/17 (2006.01) A61K 48/00 (2006.01) C07K 14/705 (2006.01) C12N 5/10 (2006.01) C12N 7/01 (2006.01) C12N 15/86 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2416893
The invention discloses immunogenic CEA agonist polypeptides/proteins comprising a modified epitope containing the amino acid sequence YLSGADLNL, nucleic acids coding therefor, vectors and/or cells comprising said nucleic acids, and mixtures and/or compositions thereof. Methods for eliciting or inducing CEA-specific immune responses utilizing the aforementioned agents are also disclosed.
La présente invention concerne, d'une part des polypeptides ou protéines agonistes de l'antigène CEA (Carcinoembryonic Antigen) immunogènes comprenant un épitope modifié contenant la séquence d'acide aminé YLSGADLNL, d'autre part des acides nucléiques codant pour eux, mais aussi des vecteurs et/ou cellules comprenant ces acides nucléiques, et enfin des mélanges et/ou compositions les intégrant. L'invention concerne également des procédés permettant de susciter ou d'induire des réponses immunitaires spécifiques du CEA par utilisation de ces agents.
Berinstein Neil
Gritz Linda
Panicali Dennis L.
Schlom Jeffrey
Tartaglia James
Aventis Pasteur Limited
Berinstein Neil
Gritz Linda
National Cancer Institute
Panicali Dennis L.
LandOfFree
Modified cea and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified cea and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified cea and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1593261